|Articles|June 15, 2002

BioPharm International

  • BioPharm International-06-01-2002
  • Volume 15
  • Issue 6

Inside Washington: Safety, Risk, and Biotechnology Regulation

Author(s)Jill Wechsler

by Jill Wechsler Concerns about product safety and stiffer FDA regulation of manufacturers may be drying up the biotech pipeline

Newsletter

Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.